We are live on
!
Find out more
CAC
Cowen and Company Portfolio holdings
AUM
$2.97B
1-Year Est. Return
105.26%
This Fund
S&P 500
This Quarter
Est. Return
-16.6%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
-$3.41M
(-0.33%)
Cap. Flow
+$220M
Cap. Flow
% of AUM
21.29%
Top 10 Holdings %
Top 10 Hldgs %
43.95%
Holding
852
New
247
Increased
177
Reduced
137
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARK Innovation ETF
ARKK
|
+$72.6M |
| 2 |
RNAM
Avidity Biosciences
RNAM
|
+$33.7M |
| 3 |
CUTR
Cutera, Inc.
CUTR
|
+$31.5M |
| 4 |
Adicet Bio
ACET
|
+$13M |
| 5 |
RBAC
RedBall Acquisition Corp.
RBAC
|
+$12.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$26.8M |
| 2 |
PMV Pharmaceuticals
PMVP
|
+$26.3M |
| 3 |
IPOF
Social Capital Hedosophia Holdings Corp. VI
IPOF
|
+$16.9M |
| 4 |
Fulcrum Therapeutics
FULC
|
+$10.4M |
| 5 |
American Express Global Business Travel
GBTG
|
+$7.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.69% |
| 2 | Financials | 13.57% |
| 3 | Materials | 7.25% |
| 4 | Technology | 4.61% |
| 5 | Industrials | 3.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
CALL
Newmont
NEM
$124B
| – | – |
-175,300
| Closed | -$883K |
|
702
OmniAb
OABI
$491M
| – | – |
-103,336
| Closed | -$1.04M |
|
703
iShares S&P 100 ETF
OEF
$20.5B
| – | – |
-5,280
| Closed | -$1.1M |
|
704
CALL
Opendoor
OPEN
$3.38B
| – | – |
-1,033
| Closed | -$1K |
|
|
705
Opendoor
OPEN
$3.38B
| – | – |
-100,923
| Closed | -$845K |
|
|
706
PUT
Opendoor
OPEN
$3.38B
| – | – |
-6,820
| Closed | -$6K |
|
707
CALL
PureCycle Technologies
PCT
$1.46B
| – | – |
-25,400
| Closed | -$12K |
|
708
CALL
PetMed Express
PETS
$42.1M
| – | – |
-10,200
| Closed | -$11K |
|
|
709
PUT
PetMed Express
PETS
$42.1M
| – | – |
-10,200
| Closed | -$56K |
|
|
710
PMV Pharmaceuticals
PMVP
$65.6M
| – | – |
-1,261,529
| Closed | -$26.3M |
|
711
ProQR Therapeutics
PRQR
$255M
| – | – |
-377,776
| Closed | -$342K |
|
712
Quantum Corp
QMCO
$464M
| – | – |
-2,500
| Closed | -$114K |
|
713
Invesco QQQ Trust
QQQ
$479B
| – | – |
-4,386
| Closed | -$1.36M |
|
714
Regions Financial
RF
$26.8B
| – | – |
-26,612
| Closed | -$592K |
|
|
715
Rivian
RIVN
$23.7B
| – | – |
-532,300
| Closed | -$26.8M |
|
|
716
PUT
Rivian
RIVN
$23.7B
| – | – |
-32,300
| Closed | -$113K |
|
717
ReNew
RNW
$2.23B
| – | – |
-141,532
| Closed | -$1.16M |
|
718
Revvity
RVTY
$12.9B
| – | – |
-1,719
| Closed | -$300K |
|
719
CALL
Shell
SHEL
$249B
| – | – |
-144,400
| Closed | -$222K |
|
|
720
PUT
Shell
SHEL
$249B
| – | – |
-13,900
| Closed | -$15K |
|
721
PUT
Sundial Growers
SNDL
$318M
| – | – |
-65,250
| Closed | -$376K |
|
722
Senti Biosciences Holdings
SNTI
$10.9M
| – | – |
-4,720
| Closed | -$466K |
|
723
Volato Group
SOAR
$9.08M
| – | – |
-1,631
| Closed | -$404K |
|
724
CALL
Sarepta Therapeutics
SRPT
$1.81B
| – | – |
-12,000
| Closed | -$30K |
|
|
725
Sarepta Therapeutics
SRPT
$1.81B
| – | – |
-7,218
| Closed | -$564K |
|
Similar funds
CIP
PWLP
FPCG
SI
BC
FTDI
CIM
PRO
Cowen and Company's Q2 2022 Portfolio in Review
As of Q2 2022, Cowen and Company held 852 positions worth $1.04B, down 0.33% from $1.04B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Cowen and Company deployed $220M of net new capital in Q2 2022, opening 247 new positions and adding to 177 existing holdings. Its largest new stake was Avidity Biosciences: 2,264,150 shares worth $32.9M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 40% a quarter earlier, followed by Financials and Materials.
On the sell side, the largest reduction was Social Capital Hedosophia Holdings Corp. VI, an estimated $16.9M trimmed.
- Cowen and Company's largest Q2 2022 buy was Avidity Biosciences: 2,264,150 shares worth $32.9M.
- Cowen and Company added most to ARK Innovation ETF in Q2 2022, an estimated $72.6M increase.
- Cowen and Company's biggest Q2 2022 reduction was Social Capital Hedosophia Holdings Corp. VI, cutting an estimated $16.9M.
- Cowen and Company fully exited Rivian in Q2 2022, selling an estimated $26.8M.
- Cowen and Company's ten largest holdings make up 44% of its $1.04B portfolio in Q2 2022.
- Cowen and Company opened 247 new positions and closed 202 in Q2 2022.
- Cowen and Company's portfolio value fell 0.33% quarter-over-quarter to $1.04B.
Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.